Acorda Therapeutics Inc (NASDAQ:ACOR)

Delayed Data
As of Apr 20
 -0.05 / -0.21%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 9 analysts offering 12-month price forecasts for Acorda Therapeutics Inc have a median target of 25.00, with a high estimate of 37.00 and a low estimate of 17.00. The median estimate represents a +7.07% increase from the last price of 23.35.

Analyst Recommendations

The current consensus among 10 polled investment analysts is to Hold stock in Acorda Therapeutics Inc. This rating has held steady since April, when it was unchanged from a Hold rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
May 02

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 10.16%
Growthannually -92.76%


Growthquarterly -29.86%
Growthannually -37.16%
Key to the earnings and sales forecast charts.